The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2, open-label, single-arm, prospective, multicenter study of nab-sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer.
 
Lauren E. Dockery
Consulting or Advisory Role - AADi
 
Brian M. Slomovitz
Consulting or Advisory Role - AstraZeneca; BioNTech SE; Eisai; EQRx; Genentech; Genmab; Gilead Sciences; GlaxoSmithKline; GOG Foundation; Lilly; Merck; Nuvation Bio; Onconova Therapeutics; Onconova Therapeutics; Regeneron; Seagen
 
Fernanda Musa
No Relationships to Disclose
 
Cara Amanda Mathews
Research Funding - AADI (Inst); Artios (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); avenge bio (Inst); Deciphera (Inst); Elucida Oncology (Inst); EMD Serono (Inst); Genmab (Inst); Immunogen (Inst); Laekna Therapeutics (Inst); Merck (Inst); Moderna Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst); Roche/Genentech (Inst); Seagen (Inst); Tesaro/GSK (Inst); Volastra Therapeutics (Inst); Zentalis (Inst)
 
Anna M. Priebe
No Relationships to Disclose
 
Angela Green
Consulting or Advisory Role - Merck
Research Funding - AADi (Inst); Lilly (Inst); Mereo BioPharma (Inst)
 
Allison Puechl
No Relationships to Disclose
 
Michael J. Birrer
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Merck
 
Nicola M. Spirtos
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); NRG/GOG FOUNDATION (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Application No. PCT/US 2019/19465 CANNABIS BASED THERAPEUTIC AND METHOD OF USE Application No.; John Wiley and Sons Editor 12th Edition Bonney's Gynaecological Surgery; Title Country Status Filed Date Application No. Patent Ref. No.199236-701611/EP Title: CANNABIS BASED THERAPEUTIC AND METHOD OF USE Country: European Patent Status: Published 2/25/2019 19710540.6 Patent Ref. No.199236-701691/PCT-BR Title: CANNA; US Patent 0024098766 Compounds Cannabidiol and Flavanones 63/047550 (7-1-20) 63/055458 (7-23-20)
 
Li Ding
Employment - AADi
Stock and Other Ownership Interests - AADi; AADi
 
Anita N. Schmid
Employment - AADi
Stock and Other Ownership Interests - AADi
 
Willis H. Navarro
Employment - AADi; Atara Biotherapeutics
Stock and Other Ownership Interests - Atara Biotherapeutics; bluebird bio; Moderna Therapeutics; Novo Nordisk; Pfizer
Consulting or Advisory Role - Imago Pharma
 
Kathleen N. Moore
Leadership - GOG Partners; NRG Oncology (Inst)
Honoraria - Great Debates and Updates; Physicans' Education Resource; Prime Oncology; Research To Practice
Consulting or Advisory Role - AADi; aadi; Alkermes (Inst); AstraZeneca; Blueprint Medicines (Inst); Caris Life Sciences; Clovis Oncology; Duality Biologics (Inst); Eisai; Genentech/Roche; GlaxoSmithKline/Tesaro (Inst); Hengrui Pharmaceutical; Immunogen; Iovance Biotherapeutics; Janssen Oncology; Merck; Mereo BioPharma; Mersana (Inst); Myriad Genetics; Novartis; Novartis/Pfizer; Onconova Therapeutics; OncXerna Therapeutics; Regeneron; VBL Therapeutics; Verastem/Pharmacyclics; zentalis
Research Funding - Agenus (Inst); Amgen (Inst); artios (Inst); AstraZeneca (Inst); Bolt Biotherapeutics (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); cyteir (Inst); Daiichi Sankyo/Lilly (Inst); Genentech (Inst); Immunocore (Inst); Immunogen (Inst); Lilly (Inst); Lilly Foundation (Inst); Merck (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Novogen (Inst); PTC Therapeutics (Inst); Regeneron (Inst); Takeda (Inst); Tesaro (Inst); Verastem (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline
Other Relationship - GOG Partners (Inst)